Cancer Genomics Testing
At AEON, we are committed to providing physicians with genomic insights and understanding that will assist in the prevention, early detection, and personalized treatment of a broad variety of cancers. Our cancer genomics testing – CGX Advantage Proﬁle – is designed to provide physicians with clinically actionable information based on the individual genomic proﬁle of each patient. Our test analyzes mutations in a patient’s DNA known to be associated with an increased risk of hereditary cancer.
We understand that as physicians, you must continually seek out ways to enhance the care you provide to each of your patients. Our Cancer Genomics tests provide information that will enhance your ability to oﬀer personalized care and therapy based on each patient’s speciﬁc genomic mutation and associated cancer.